Loading
OO
OmniAb Operations, Inc. Stock: price and insider trades · United States
OmniAb Operations, Inc.: what insiders have been doing
Insider filings for OmniAb Operations, Inc. are scarce in the SEC (Form 4) feed, the latest one published on 3 November 2022. This page will fill in as new trades are disclosed. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
7
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Last declaration on 3 November 2022
Declarations7 total
212,362 sharesCommon StockSEC:0000899243-22-035048:1
17,792 sharesCommon StockSEC:0000899243-22-035057:1
52,587 sharesCommon StockSEC:0000899243-22-035045:1
16,859,308 shares0Common StockSEC:0000899243-22-035055:0
26,193 shares0Common StockSEC:0000899243-22-035048:0
17,792 shares0Common StockSEC:0000899243-22-035057:0
15,409 shares0Common StockSEC:0000899243-22-035045:0
7 of 7 declarations
About OmniAb Operations, Inc.
OmniAb Operations, Inc. is a company listed on the XNAS market. It specializes in developing technologies for antibody discovery.
